E. Spilcke-Liss

Endocrine tumors of the pancreas.

H. Wallaschofski, P. Simon, E. Spilcke-Liss, 2006, Endocrinology and metabolism clinics of North America.

IGF-1: Analytik und Referenzbereiche / Measurement of IGF-1 and reference ranges

N. Friedrich, H. Wallaschofski, E. Spilcke-Liss, 2008 .

Five commercially available insulin-like growth factor I (IGF-I) assays in comparison to the former Nichols Advantage IGF-I in a growth hormone treated population

G. Brabant, H. Völzke, T. Kohlmann, 2008, Clinical chemistry and laboratory medicine.

Serum insulin‐like growth factor I and its binding protein 3 in their relation to intima–media thickness: results of the study of health in Pomerania (SHIP)

G. Brabant, H. Völzke, U. Schminke, 2011, Clinical endocrinology.

Enhanced platelet activation by prolactin in patients with ischemic stroke

W. Daniel, H. Wallaschofski, C. Stumpf, 2004, Thrombosis and Haemostasis.

Mortality and serum insulin-like growth factor (IGF)-I and IGF binding protein 3 concentrations.

G. Brabant, J. Lüdemann, H. Völzke, 2009, The Journal of clinical endocrinology and metabolism.

Reference ranges of serum IGF-1 and IGFBP-3 levels in a general adult population: results of the Study of Health in Pomerania (SHIP).

J. Lüdemann, D. Alte, H. Völzke, 2008, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.